Pancreatic Cancer Research

ResearcherArizona State UniversityActive in the last 2 years

Yang Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5125574348. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 9

  1. Identifying Bridge Symptoms Linking Physical and Psychological Burdens in Postoperative Pancreatic Cancer Patients: A Network Analysis. Co-author DOI 10.1002/pon.70400↗
  2. Exploring the Dynamics of Perioperative Quality of Life in Patients with Pancreatic Cancer: A Cross-Lagged Panel Network Analysis. Co-author DOI 10.1245/s10434-026-19155-6↗
  3. ASO Visual Abstract: Exploring the Dynamics of Perioperative Quality of Life in Patients with Pancreatic Cancer: A Cross-Lagged Panel Network Analysis. Co-author DOI 10.1245/s10434-026-19315-8↗
  4. Risk Factors for Financial Toxicity in Patients With Pancreatic Cancer. Co-author DOI 10.1002/cam4.70799↗
  5. Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41421-021-00366-y↗
  6. Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC. First author DOI 10.3389/fcell.2022.762372↗
  7. DDX31: A Novel Functional Oncogene Promotes Migration and Proliferation of Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-520114/v1↗
  8. OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.698302↗
  9. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer. Co-author DOI 10.7150/thno.26650↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuelin Song · 3 shared papers, 2026 · strength 1.00
  2. Shumei Zhuang · 3 shared papers, 2026 · strength 1.00
  3. Shimei Jin · 3 shared papers, 2026 · strength 1.00
  4. Jiayi Liu · 2 shared papers, 2026 · strength 0.67
  5. Jinsheng Ding · 3 shared papers, 2021–2022 · strength 0.48
  6. Yongjie Xie · 3 shared papers, 2021–2022 · strength 0.48
  7. Liangliang Wu · 2 shared papers, 2021–2022 · strength 0.36
  8. Zhi-Hua Li · 1 shared paper, 2025 · strength 0.30
  9. Baoxin Shi · 1 shared paper, 2025 · strength 0.30
  10. Jing Wang · 1 shared paper, 2025 · strength 0.30
  11. Bo Ni · 1 shared paper, 2022 · strength 0.16
  12. Danqi Fu · 1 shared paper, 2022 · strength 0.15
  13. Xiaoying Fan · 1 shared paper, 2022 · strength 0.15
  14. Ping Lü · 1 shared paper, 2022 · strength 0.15
  15. Fuchou Tang · 1 shared paper, 2022 · strength 0.15
  16. Xinglong Wu · 1 shared paper, 2022 · strength 0.15
  17. Jihui Hao · 1 shared paper, 2022 · strength 0.15
  18. Yizhang Zhou · 1 shared paper, 2021 · strength 0.12
  19. Chuntao Gao · 1 shared paper, 2021 · strength 0.12
  20. Huizhi Sun · 1 shared paper, 2021 · strength 0.12
  21. Matthew H. G. Katz · 1 shared paper, 2018 · strength 0.08
  22. Qian Wei · 1 shared paper, 2018 · strength 0.08
  23. Ye Hu · 1 shared paper, 2018 · strength 0.08
  24. Haiyong Han · 1 shared paper, 2018 · strength 0.08
  25. Eugene Jon Koay · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.